In Conversation: Jordan Feldman
CEO & Co-Founder, Rightway - on rightway's growth numbers and its pitch as a transparent, aligned alternative to the big three pharmacy benefit managers
Some of the clearest thinking in digital health today comes from Jordan Feldman, CEO & Co-Founder, Rightway. In a wide-ranging conversation conducted by Fierce Healthcare, Jordan laid out a view of the industry that is both candid and immediately useful to the executives, clinicians, and builders who read HealthTech Cube.
The conversation
Rightway's growth numbers and its pitch as a transparent, aligned alternative to the big three pharmacy benefit managers - with member experience and drug cost savings at the center.
“Become the clear alternative to the Big 3 PBMs.”
- Jordan Feldman, in conversation with Fierce Healthcare
Conversation highlights
Rightway's growth numbers and its pitch as a transparent
Aligned alternative to the big three pharmacy benefit managers
With member experience and drug cost savings at the center
The bigger picture
The capital context matters here. US digital health raised $7.4 billion in H1 2026 with 45% of it concentrated in $100M+ megadeals, and 115 acquisitions made it the busiest M&A run since 2021 (our analysis). In a market this concentrated, the strategies described in this conversation - defensible data, measurable outcomes, disciplined growth - are precisely what separates the funded from the folded.
The exchange offers a rare unvarnished look at how these decisions actually get made. At Rightway, that thinking translates into daily decisions about where technology genuinely earns its place in care delivery, and where discipline matters more than novelty.
The HTC take
As the reimbursement and regulatory ground shifts through 2026 and 2027, this is exactly the kind of leadership thinking worth revisiting.